John B. Harlow Jr. Esperion Therapeutics, Inc. (ESPR) insider trading activity

ESPR Quotes by TradingView

John B. Harlow Jr. is Chief Commercial Officer of Esperion Therapeutics, Inc.. Currently has a direct ownership of 424,536 shares of ESPR, which is worth approximately $1.23 Million. The most recent transaction as insider was on Dec 04, 2025, when has been sold 424,536 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 425K
n/a 3M change
n/a 12M change
Total Value Held $1.23 Million

John B. Harlow Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2025
BUY
Grant, award, or other acquisition
-
424,536 Added 50.0%
424,536 Common Stock
JBH

John B. Harlow Jr.

Chief Commercial Officer
Ann Arbor, MI

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ESPR